Simeox 200 US Study
← catalyst calendarSponsored by Inogen Inc. (industry) · INGN — their whole pipeline →.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
35estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Feb 2026 | estimated | When the study began enrolling |
| Primary completion | May 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-02 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-02 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Bronchiectasis
- Mucus; Plug
Intervention
- Device: Intermittent intrapulmonary deflation
Primary outcome
what the primary-completion date above is the date OFWet sputum weight collected with Simeox 200 during device training visit
measured From the first training session to the last, and up to one hour following each treatment session the day of training device visit.
Permalink · INGN's whole pipeline · Catalyst calendar · Every registered study · What changed